Sodium antimony gluconate, amphotericin, and myocardial damage

Lancet. 1998 Jun 27;351(9120):1928-9. doi: 10.1016/s0140-6736(05)78612-8.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Amphotericin B / adverse effects*
  • Amphotericin B / therapeutic use
  • Antimony Sodium Gluconate / adverse effects
  • Antimony Sodium Gluconate / therapeutic use*
  • Antiprotozoal Agents / adverse effects*
  • Antiprotozoal Agents / therapeutic use
  • Arrhythmias, Cardiac / chemically induced*
  • Arrhythmias, Cardiac / diagnosis
  • Electrocardiography
  • Female
  • Humans
  • Leishmaniasis, Visceral / drug therapy*
  • Male

Substances

  • Antiprotozoal Agents
  • Amphotericin B
  • Antimony Sodium Gluconate